Compare AIP & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIP | CTKB |
|---|---|---|
| Founded | 2003 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 767.5M | 652.1M |
| IPO Year | 2021 | 2021 |
| Metric | AIP | CTKB |
|---|---|---|
| Price | $14.50 | $4.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $16.83 | $5.70 |
| AVG Volume (30 Days) | 492.5K | ★ 782.3K |
| Earning Date | 01-01-0001 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $70,579,000.00 | ★ $193,015,000.00 |
| Revenue This Year | $30.24 | $5.02 |
| Revenue Next Year | $19.50 | $7.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 22.27 | 17.67 |
| 52 Week Low | $5.64 | $2.37 |
| 52 Week High | $19.85 | $6.18 |
| Indicator | AIP | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 41.79 | 33.16 |
| Support Level | $13.58 | $4.00 |
| Resistance Level | $14.64 | $4.26 |
| Average True Range (ATR) | 1.03 | 0.22 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 21.02 | 23.00 |
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.